Oxidative Medicine and Cellular Longevity, 2022
The therapy as a shared effect, noted in the severe ischemia condition, as well as in advanced reperfusion, consistently and rapidly counteracts occlusion/occlusion-like syndrome as a whole, restoring function by effectively bypassing loops of minor vessels (e.g., direct blood flow [129,130,131,132,133,134,135,136,137,138,139,140,141,142,168] via the azygos vein) to counteract the failure of major vessels [129,130,131,132,133,134,135,136,137,138,139,140,141,142,168]
It is characterised by its selective interaction with NNMT (Nicotinamide-N-Methyltransferase) , an enzyme implicated in a range of metabolic and biochemical regulatory processes, making it a valuable reference compound for preclinical and in-vitro research programmes
Potential Impact: If 2.4mg/2.4mg achieves 20.4% weight loss, could 2.4mg/7.2mg achieve 25-27%
Given its sleep-inducing and neuroprotective effects, DSIP has been proposed as a potential therapeutic agent for a variety of conditions, including sleep disorders, chronic pain, and neurodegenerative diseases